• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Align Technology Announces Invisalign® System With Mandibular Advancement Featuring Occlusal Blocks for Class II Skeletal and Dental Correction

    11/24/25 8:00:00 PM ET
    $ALGN
    Industrial Specialties
    Health Care
    Get the next $ALGN alert in real time by email

    Offers an Innovative Treatment Option for Class II Skeletal Malocclusion in Kids and Teenage Patients While Simultaneously Straightening their Teeth

    Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced commercial availability in the Philippines of the Invisalign System with mandibular advancement featuring occlusal blocks designed specifically to address Class II skeletal and dental correction by simultaneously advancing the mandible while aligning the teeth. This innovative solution is Align's first clear aligner product with integrated solid occlusal blocks that is designed to deliver predictable mandibular advancement. Invisalign occlusal blocks provide durability, improve engagement, and enable vertical opening to offer earlier advancement of the mandible in cases like skeletal Class II with deep bite to improve treatment efficiency.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251124460195/en/

    The Invisalign® System with mandibular advancement featuring occlusal blocks is the latest clinical innovation that expands Align's Class II treatment portfolio for growing patients by offering practitioners a comprehensive solution for treating growing patients with Class II malocclusions caused by mandibular retrusion.

    The Invisalign® System with mandibular advancement featuring occlusal blocks is the latest clinical innovation that expands Align's Class II treatment portfolio for growing patients by offering practitioners a comprehensive solution for treating growing patients with Class II malocclusions caused by mandibular retrusion.

    The Invisalign System with mandibular advancement featuring occlusal blocks is the latest clinical innovation that expands Align's Class II treatment portfolio for growing patients by offering practitioners a comprehensive solution for treating growing patients with Class II malocclusions caused by mandibular retrusion. Class II malocclusion is one of the most common orthodontic problems, characterized by a discrepancy in jaw alignment where the lower jaw (mandible) is positioned too far back relative to the upper jaw (maxilla) and represents approximately 30-45% of malocclusions globally. This condition can lead to functional, aesthetic, and other challenges for patients if left untreated.

    The Invisalign System with mandibular advancement featuring occlusal blocks is primarily intended for growing patients in the late mixed or early permanent dentition stages (ages 10-16), who are still experiencing growth. By leveraging the natural growth potential during pre-adolescence and adolescence, the Invisalign System with mandibular advancement featuring occlusal blocks facilitates effective correction of Class II malocclusions, helping to improve occlusal relationships, enhance facial aesthetics, and provide long-term functional benefits, including:

    • Efficient treatment. Minimizes the need for multiple appliances to treat conditions including severe deep bite. Treats Class II malocclusions while simultaneously aligning the teeth in a single, efficient process. Invisalign occlusal blocks are solid with laser welding, which ensures structural rigidity and durability throughout the treatment, to minimize crushing. The solid occlusal blocks allow for vertical opening and enables the Mandibular Advancement (MA) phase to begin sooner for Class ll deep bite cases or Class II div 2 patients who many times would have needed a pre-MA phase. Some crossbite cases may still need pre-MA.
    • Elevated patient comfort,(1) and compliance(2). Made from patented SmartTrack™ material, which is predictable and more comfortable(1). Studies show that patient discomfort with functional appliances affects patient compliance with the prescribed wear time and could lead to unsatisfactory outcomes(2).
    • Predictable tooth movement. Attachments are allowed on the teeth under the blocks to facilitate leveling and other movement or to help prevent unwanted movements(3). By combining SmartTrack™ material, SmartForce™ features, and SmartStage™ technology, it also allows for more predictable tooth movement (1).

    "The Invisalign System with mandibular advancement featuring occlusal blocks reflects Align's continued commitment to expanding the capabilities of the Invisalign System, enabling doctors to treat a wider range of malocclusions with precision and efficiency, and helps to continue to advance clear aligners as the standard of care in digital orthodontics," said Sreelakshmi Kolli, Align Technology EVP, chief product and digital officer. "This latest innovation demonstrates our significant investment in delivering digital orthodontic solutions to growing patients that empower doctors to achieve predictable outcomes while enhancing the patient experience."

    "The Invisalign System with mandibular advancement featuring occlusal blocks represents a breakthrough in Class II treatment with clear aligners by allowing doctors to simultaneously address dental and skeletal discrepancies in a more predictable and efficient manner," said Dr. Mitra Derakhshan, Align Technology EVP and chief clinical officer. "The integration of occlusal blocks enhances mandibular engagement as well as provides bite opening making this a versatile solution for different Class II malocclusion including deep bite or div 2. The Invisalign System with mandibular advancement featuring occlusal blocks, gives doctors and patients a better option for Class II correction in growing patients while simultaneously straightening their teeth, including more options for feature placement, such as attachments on teeth underneath the blocks (3)."

    "Treatment outcomes with the Invisalign System with mandibular advancement featuring occlusal blocks are on par with traditional Clark Twin Blocks," said Dr. Ronald Sluiter, an orthodontist practicing in New Zealand who has treated 50 patients to date. "In addition, the enhanced comfort of the Invisalign occlusal blocks increases predictability-- because comfort leads to patient compliance–and compliance leads to better outcomes."

    "Class II correction in growing patients is smooth sailing with the Invisalign System with mandibular advancement featuring occlusal blocks," said Dr. Steve Semaan, an orthodontist practicing in Australia. "The patients instinctively know how to bite, and it works so I don't see any crushed blocks. The fact that we see no crushing issues means patients can keep moving through treatment without any delays or additional appointments."

    "I'm very happy with the new Invisalign System with mandibular advancement featuring occlusal blocks design," said Dr. Belinda Weltman, Vancouver, Canada. "Patients can bite down easily without risk of damaging or distorting the blocks, and the mandibular advanced position is easy to maintain. My young patients have found it very easy to transition to this appliance with minimal discomfort, and compliance has been a breeze."

    "The Invisalign System with mandibular advancement featuring occlusal blocks provides the ideal block engagement that helps hold the mandible in the proper position for patients that also have mandibular asymmetry. This allows for more efficient corrections when desired," said Dr. Francis Janisse, Windsor, Canada. "Invisalign system with mandibular advancement featuring occlusal blocks removes the need for auxiliary elastics, which removes one more obstacle for patients. In addition, the trays do not require palatal coverage like traditional removable Class ll correctors, and there are no changes in the insertion and removal process of the aligners. My younger patients love the ability to remove the aligners for eating, which is not commonly an option for patients that require fixed Class ll correctors or elastics."

    The Invisalign System with mandibular advancement featuring occlusal blocks is now commercially available to Invisalign-trained doctors in Australia, New Zealand, Japan, Hong Kong, Malaysia, Singapore, India, Korea, China, Thailand and Vietnam. Along with the Invisalign® Palatal Expander System, Invisalign First™ and Invisalign System with mandibular advancement featuring occlusal blocks, this latest innovation supports the commitment to establishing a unique and differentiated portfolio that supports growing patients throughout their continuum of care.

    For more information about the Invisalign System with mandibular advancement featuring occlusal blocks, or to schedule a training session, please visit www.invisalign.com.ph or contact your local Align Technology representative.

    1. Compared to Invisalign aligners previously made from single-layer (EX30) material.

    2. Studies show that patient discomfort with functional appliances affect patient compliance with the prescribed wear time and could lead to unsatisfactory outcomes. https://pubmed.ncbi.nlm.nih.gov/34949565/

    3. In some cases, attachments may be removed on teeth under occlusal blocks due to interferences with other features.

    About Align Technology, Inc.

    Align Technology designs and manufactures the Invisalign® System, the most advanced clear aligner system in the world, iTero™ intraoral scanners and services, and exocad™ CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for over 291.0 thousand doctor customers and are key to accessing Align's 600 million consumer market opportunity worldwide. Over the past 28 years, Align has helped doctors treat approximately 21.4 million patients with the Invisalign System and is driving the evolution in digital dentistry through the Align™ Digital Platform, our integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab/partners. Visit www.aligntech.com for more information.

    For additional information about the Invisalign System or to find an Invisalign doctor in your area, please visit www.invisalign.com.ph. For additional information about the iTero digital scanning system, please visit www.itero.com/en-APAC. For additional information about exocad dental CAD/CAM offerings and a list of exocad reseller partners, please visit www.exocad.com.

    Invisalign, iTero, exocad, Align, Align Digital Platform, and iTero Lumina are trademarks of Align Technology, Inc.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20251124460195/en/

    Align Technology

    Madelyn Valente

    (909) 833-5839

    [email protected]

    Zeno Group

    Sarah Karlson

    (828) 551-4201

    [email protected]

    Get the next $ALGN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALGN

    DatePrice TargetRatingAnalyst
    10/10/2025$140.00Buy → Hold
    Jefferies
    7/31/2025$154.00Overweight → Equal-Weight
    Morgan Stanley
    4/25/2025$170.00Buy → Hold
    HSBC Securities
    2/14/2025$255.00Overweight
    Wells Fargo
    1/6/2025$235.00 → $280.00Market Perform → Outperform
    Leerink Partners
    12/4/2024$295.00Outperform
    Mizuho
    10/10/2024Hold
    Needham
    2/26/2024$310.00Market Perform
    Leerink Partners
    More analyst ratings

    $ALGN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Align Tech downgraded by Jefferies with a new price target

    Jefferies downgraded Align Tech from Buy to Hold and set a new price target of $140.00

    10/10/25 8:22:21 AM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Tech downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded Align Tech from Overweight to Equal-Weight and set a new price target of $154.00

    7/31/25 7:16:13 AM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Tech downgraded by HSBC Securities with a new price target

    HSBC Securities downgraded Align Tech from Buy to Hold and set a new price target of $170.00

    4/25/25 8:29:20 AM ET
    $ALGN
    Industrial Specialties
    Health Care

    $ALGN
    SEC Filings

    View All

    SEC Form 10-Q filed by Align Technology Inc.

    10-Q - ALIGN TECHNOLOGY INC (0001097149) (Filer)

    11/5/25 4:06:43 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Technology Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - ALIGN TECHNOLOGY INC (0001097149) (Filer)

    10/29/25 4:05:15 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Technology Inc. filed SEC Form 8-K: Leadership Update

    8-K - ALIGN TECHNOLOGY INC (0001097149) (Filer)

    9/18/25 5:04:39 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    $ALGN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, CHIEF LEGAL & REGULATORY Coletti Julie Ann bought $4,606 worth of shares (42 units at $109.66), increasing direct ownership by 0.59% to 7,110 units (SEC Form 4)

    4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

    8/1/25 5:58:45 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    PRESIDENT AND CEO Hogan Joseph M bought $996,131 worth of shares (7,576 units at $131.49), increasing direct ownership by 4% to 184,945 units (SEC Form 4)

    4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

    8/1/25 4:05:18 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    SEC Form 4 filed by Director Vitalone Britt J.

    4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

    7/7/25 4:13:42 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    $ALGN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Align Technology Recognized for the 3rd Time in Extel's 2025 All-America Executive Team Rankings, Including the Most Honored Company Distinction

    Company, board of directors, and executives earns multiple #1, #3 and top 10 rankings across leadership, governance, and investor relations categories in the Health Care Technology & Distribution sector and Large-Cap ($10B–$50B) market segment Align Technology, Inc. ("Align") (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced top-tier recognition in the 2025 All-America Executive Team rankings published by Extel Insights (formerly Institutional Investor Research), which evaluates the qu

    11/25/25 7:02:00 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Technology Announces Invisalign® System With Mandibular Advancement Featuring Occlusal Blocks for Class II Skeletal and Dental Correction

    Offers an Innovative Treatment Option for Class II Skeletal Malocclusion in Kids and Teenage Patients While Simultaneously Straightening their Teeth Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced commercial availability in the Philippines of the Invisalign System with mandibular advancement featuring occlusal blocks designed specifically to address Class II skeletal and dental correction by simultaneously advancing the mandible while aligning the teeth. This

    11/24/25 8:00:00 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Technology to Speak at Upcoming Financial Conferences

    Align Technology, Inc. ("Align") (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that the company is scheduled to speak at upcoming financial conferences. As noted below, the presentations will be webcast live via the Investor Relations section of Align Technology's website at http://investor.aligntech.com. An archived replay will remain on the website for approximately one month. Conference: UBS Global Healthcare Conference   Date: Tuesday, November 11, 2025  

    11/4/25 4:01:00 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    $ALGN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, CHIEF LEGAL & REGULATORY Coletti Julie Ann bought $4,606 worth of shares (42 units at $109.66), increasing direct ownership by 0.59% to 7,110 units (SEC Form 4)

    4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

    8/1/25 5:58:45 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    PRESIDENT AND CEO Hogan Joseph M bought $996,131 worth of shares (7,576 units at $131.49), increasing direct ownership by 4% to 184,945 units (SEC Form 4)

    4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

    8/1/25 4:05:18 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    Director Larkin C Raymond Jr bought $1,529,645 worth of shares (6,500 units at $235.33) and gifted 4,650 shares, increasing direct ownership by 9% to 23,597 units (SEC Form 4)

    4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

    8/19/24 6:35:02 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    $ALGN
    Leadership Updates

    Live Leadership Updates

    View All

    Align Technology's Invisalign® Brand Announces Official Sponsorship of Bay FC

    Sponsorship of National Women's Soccer League (NWSL) team highlights inspirational smile stories of women in sports and will help expand access to youth sports across the Bay Area Bay FC, the professional soccer franchise representing the San Francisco Bay Area in the National Women's Soccer League (NWSL), and Align Technology, a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that Align Technology's Invisalign brand is an Official Partner of Bay FC. Through the sponsorship, Bay FC players who are

    3/25/25 4:00:00 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Technology Appoints Emory Wright, EVP Direct Fabrication Manufacturing Platform to Build the Company's Next Generation Manufacturing Operations -- Wright Plans to Retire in 2026

    Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced it has appointed Emory Wright, executive vice president, direct fabrication manufacturing platform, effective immediately. Mr. Wright will transition his current responsibilities for global operations, including treatment planning, and focus on scaling Align's next generation direct fabrication manufacturing platform, working in close collaboration with Srini Kaza, who was promoted to executive vice president, res

    5/22/24 5:00:00 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Technology Appoints Karim Boussebaa, EVP and MD of iTero Scanner and Services Business—Yuval Shaked to Leave Align End of 2023

    Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that after nearly six years with Align, Yuval Shaked, executive vice president and managing director of iTero scanner and services, has decided to leave the company for personal reasons and spend more time with his family. He will remain with Align and continue as a member of Align Technology President and CEO Joe Hogan's staff supporting strategic initiatives and programs through 2023. Mr. Shaked will transition

    2/8/23 4:55:00 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    $ALGN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Align Technology Inc. (Amendment)

    SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)

    2/13/24 4:59:02 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    SEC Form SC 13G/A filed by Align Technology Inc. (Amendment)

    SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)

    2/9/24 4:31:42 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    SEC Form SC 13G/A filed by Align Technology Inc. (Amendment)

    SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)

    2/9/23 11:07:31 AM ET
    $ALGN
    Industrial Specialties
    Health Care

    $ALGN
    Financials

    Live finance-specific insights

    View All

    Align Technology Announces Third Quarter 2025 Financial Results

    Q3'25 total revenues were $995.7 million, up 1.8% year-over-year and down 1.7% sequentially, as expected, and above our guidance Q3'25 Clear Aligner volume increased 4.9% year-over-year reflecting strength internationally, and increased 0.5% sequentially reflecting strength from teens and kids Q3'25 Clear Aligner volume for teens and kids increased 8.3% year-over-year and 14.7% sequentially, driven by increased doctor submitters and continued adoption of Invisalign First™ Q3'25 total revenues were $995.7 million, up 1.8% year-over-year and down 1.7% sequentially, as expected, and above our Q3'25 outlook range of $965 million to $985 million Q3'25 total revenues were favorably impa

    10/29/25 4:03:00 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Technology to Announce Third Quarter 2025 Results on October 29, 2025

    Align Technology, Inc. (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report third quarter 2025 financial results on Wednesday, October 29, 2025, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com. Following the press release, Align will host a conference call to discuss its financial results. The conference call will b

    10/1/25 8:30:00 AM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Technology Announces Second Quarter 2025 Financial Results

    Q2'25 total revenues were $1,012.4 million, up 3.4% sequentially and down 1.6% year-over-year Q2'25 total revenues were favorably impacted by foreign exchange by approximately $26.4 million, or 2.7% sequentially, and favorably impacted by approximately $5.6 million, or 0.6% year-over-year(1) Q2'25 Clear Aligner revenues were $804.6 million, up 1.0% sequentially and down 3.3% year-over-year Q2'25 Clear Aligner volume was 644.4 thousand cases, up 0.3% sequentially and year-over-year Q2'25 Imaging Systems and CAD/CAM Services revenues were $207.8 million, up 13.9% sequentially and up 5.6% year-over-year Q2'25 operating income of $163.0 million and operating margin of 16.1%, non

    7/30/25 4:14:00 PM ET
    $ALGN
    Industrial Specialties
    Health Care